李小加今年底提早退任港交所(00388.HK)行政總裁轉任高級顧問 戴志堅將出任代理集團行政總裁
港交所(00388.HK)公布,早前行政總裁李小加擬於其現時合約在2021年10月屆滿後不再尋求續任港交所集團行政總裁,在董事會全面支持及同意下,李小加將繼續擔任港交所行政總裁直至2020年12月31日,由2021年1月1日起李小加將轉任為董事會高級顧問,為期6個月,並將繼續提供指導確保過渡安排順利進行。
董事會宣布委任戴志堅出任代理集團行政總裁,有關委任將於2021年1月1日生效。戴志堅現年58歲,現時出任港交所聯席總裁及首席營運總監,在其代理集團行政總裁的委任於2021年1月1日生效後,他將同時繼續擔任該等職務。(el/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.